Kleo Pharmaceuticals, Inc. — Form D
Kleo Pharmaceuticals, Inc. of NEW HAVEN, CT, a company, filed a Form D exempt-offering notice with the SEC on 2019-01-15. The offering totals $21.2M, of which $21.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-01-15
- Form: D
- Accession: 0000945621-19-000016
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $21.2M
- Amount sold: $21.2M
- Investors: 19
- Date of first sale: 2018-11-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-330541
Issuer
- Name: Kleo Pharmaceuticals, Inc.
- CIK: 0001700389
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 25 SCIENCE PARK, SUITE 2D, NEW HAVEN, CT, 06511
- Phone: 203-691-6332
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| John W Childs | Director | Houston, TX |
| Declan Doogan | Director | Glasgow, X0 |
| Charles G Drake | Director | New York, NY |
| Alexander Goor | Director | New Haven, CT |
| Douglas Manion | Director | New Haven, CT |
| Roy Prieb | Director | New Haven, CT |
| Douglas Manion | Executive Officer | New Haven, CT |
| Roy Prieb | Executive Officer | New Haven, CT |
| David Spiegel | Director | Lewiston, ME |
| David Spiegel | Executive Officer | Lewiston, ME |
| Douglas G Manion | Executive Officer | New Haven, CT |
Other filings by this issuer (3)
More